CN101199687A - Medicament compound for treating chronic prostatitis and preparing method thereof - Google Patents
Medicament compound for treating chronic prostatitis and preparing method thereof Download PDFInfo
- Publication number
- CN101199687A CN101199687A CNA2007101783333A CN200710178333A CN101199687A CN 101199687 A CN101199687 A CN 101199687A CN A2007101783333 A CNA2007101783333 A CN A2007101783333A CN 200710178333 A CN200710178333 A CN 200710178333A CN 101199687 A CN101199687 A CN 101199687A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chronic prostatitis
- rhizoma rhei
- poria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a medicine combination for treating chronic prostatitis. The combination is prepared mainly by twelve drugs, namely, Rhubarb, Amur Cork-tree Bark, European Verbena Herb, Baical Skullcap Root, Radix Salviae Miltiorrhizae, Chinese Thorowax Root, Cowherb Seed, Earthworm, Lighiyellow Sophora Root, Milkvetch Root, Semen Plantaginis and Indian Bread. With the functions of clearing away heat and toxic material, activating blood and dredging collaterals, the drug combination of the invention is used for treating the symptoms of frequency of micturition, urgency of micturition, pain in urethra, stranguria with turbid discharge, sexual hypoesthesia, impotence and prospermia all caused by chronic prostatitis. The Chinese traditional medicine combination is used for clinic, achieving 61.60 percent of efficient rate and 89.60 percent of total effective rate. With accurate effect, safety, convenience and less side effects, the invention has wide application value.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition for the treatment of chronic prostatitis, belong to the prostatitic technical field of pharmaceuticals of treatment.Be used for the treatment of diseases such as frequent micturition due to the chronic prostatitis, urgent micturition, Urethra astringent pain, stranguria with turbid discharge, hyposexuality, impotence and premature ejaculation.
Background technology
Chronic prostatitis is the disease of a kind of sickness rate very high (4%～25%), and the man near 50% is in its influence that will suffer from the prostatitis symptom sometime in life.At present PRELIMINARY RESULTS shows: prostate infects can occur in all age group, maximum with adult male, is that the right side of fifty male goes to a doctor in the common cause of Urology Surgery.Because its cause of disease, pathological change, clinical symptoms complexity are various, and have certain influence to male's sexual function and reproductive function, seriously influenced patient's quality of life, make their spirit and the human body suffer great torment.
Primary disease belongs to the traditional Chinese medical science and belongs to categories such as " stranguria caused by overstrain, smart turbid, nebulousurines ".Its main diseases is because of there being following several: the scorchingly hot heresy of (1) diseases caused by exogenous pathogenic factor, and be reluctant to leave and do not go, or sexual behavior is unclean, damp and hot staying in smart chamber, essence is turbid to be obscured, smart in its position; (2) the phase hyperactivity of fire is contained, and is willing to or bears essence and do not let out that the kidney fire stagnation is and diffusing unsuccessful because of institute, and refining of offing normal is nebulousurine; (3) chamber is excessive, exhausting its essence, smart chamber inanition, damp and hot seizing the opportunity attacked into smart chamber, smart by force, can not Jing Zang.Because of its kidney fire stagnation does not loose, or damp and hot stagnant for a long time unclear, and smart road stagnation of QI-blood is so delay is difficult.
Primary disease adopts the antibiotic therapy unsatisfactory curative effect, and this is because in the chronic prostatitis major part being arranged is agnogenic non-bacteria inflammation, and is irrelevant with bacterial infection.In addition, because the barrier permeability that capsula prostatica forms is poor, antibacterials are difficult for infiltrating into this position and reach effective drug level, cause the antibiotic therapy effect not good enough.
In recent years, some prepare the treatment by Chinese herbs chronic prostatitis, as " a kind of medicine for the treatment of chronic prostatitis and preparation method thereof " that the CN1424104 patent application proposes, it is the capsule by the preparation of Chinese medicines such as Radix Salviae Miltiorrhizae, Pollen Typhae, Radix Notoginseng, Radix Et Rhizoma Rhei, the Radix Linderae, Fructus Evodiae, Cortex Phellodendri, Radix Sophorae Flavescentis, Herba Taraxaci, Herba Verbenae." a kind of medicine for the treatment of chronic prostatitis and preparation method thereof " that the CN1562114 patent application proposes is the preparation by the preparation of Chinese medicines such as Rhizoma Smilacis Glabrae, Rhizoma Polygoni Cuspidati, Carapax Trionycis, Rhizoma Curcumae, Herba Epimedii, the Radix Astragali, Fructus Lycii.And for example " treatment chronic prostatitis compound Chinese medicinal preparation and preparation method thereof " of CN1444987 patent application proposition is the preparation by the preparation of Chinese medicines such as Hirudo, Radix Et Rhizoma Rhei, Herba Leonuri, Herba Taraxaci, Flos Carthami, Pheretima, the Radix Astragali, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Endothelium Corneum Gigeriae Galli and Radix Bupleuri.Different Chinese medicine preparations, the preparation effect that makes is also different.
Summary of the invention
The object of the present invention is to provide a kind of determined curative effect, safe ready, the Chinese medicine of the treatment chronic prostatitis that side effect is little.
The present invention also provides this preparation method of Chinese medicine.
Pharmaceutical composition heat-clearing and toxic substances removing of the present invention, it is treating stranguria to invigorate blood circulation.Can be used for treating diseases such as frequent micturition due to the chronic prostatitis, urgent micturition, Urethra astringent pain, stranguria with turbid discharge, hyposexuality, impotence and premature ejaculation.
Chinese medicine of the present invention is prepared from by the following weight parts proportion raw material:
10～30 parts in 5～20 parts of Poria of 10～30 portions of Semen Plantaginiss of 5～20 parts of Radixs Astragali of 5～20 parts of Radix Sophorae Flavescentiss of 10～30 parts of Pheretimas of 3～15 parts of Semen Vaccariae of 10～30 parts of Radix Bupleuri of 20～50 parts of Radix Salviae Miltiorrhizaes of 10～30 parts of Herba Violaes of 9～20 portions of Herba Verbenae of 5～40 portions of Cortex Phellodendris of Radix Et Rhizoma Rhei
Chinese medicine of the present invention is prepared from by following preferred weight part proportion raw material:
10～20 parts in 9～15 parts of Poria of 10～20 portions of Semen Plantaginiss of 9～15 parts of Radixs Astragali of 9～15 parts of Radix Sophorae Flavescentiss of 10～20 parts of Pheretimas of 5～10 parts of Semen Vaccariae of 10～20 parts of Radix Bupleuri of 25～40 parts of Radix Salviae Miltiorrhizaes of 10～20 parts of Herba Violaes of 10～15 portions of Herba Verbenae of 10～30 portions of Cortex Phellodendris of Radix Et Rhizoma Rhei
Chinese medicine of the present invention is prepared from by following optimum weight part proportion raw material:
15 parts in 10 parts of Poria of 15 portions of Semen Plantaginiss of 10 parts of Radixs Astragali of 10 parts of Radix Sophorae Flavescentiss of 15 parts of Pheretimas of 6 parts of Semen Vaccariae of 15 parts of Radix Bupleuri of 30 parts of Radix Salviae Miltiorrhizaes of 15 parts of Herba Violaes of 12 portions of Herba Verbenae of 20 portions of Cortex Phellodendris of Radix Et Rhizoma Rhei
Chinese medicine of the present invention can be prepared from by following method:
1, Radix Et Rhizoma Rhei 70% ethanol extraction.
2, Pheretima, Poria, astragalus membranaceus powder are become coarse powder.
3,8 flavors such as all the other Cortex Phellodendris boil twice with 8～10 times decocting, and 0.5～4 hour for the first time, 0.5～3 hour second time.
4, collecting decoction filters, and filtrate concentrates, and adds powder and Radix Et Rhizoma Rhei ethanol extract such as Pheretima, and is dry below 80 ℃, is ground into fine powder, encapsulated getting final product.
Wherein said Radix Et Rhizoma Rhei is the dry root and rhizome of polygonum rheum palmatum Rheum palmatum L., Rheum tanguticum Rheum tanguticum Maxim.ex Balf. or Rheum officinale Rheum officinale Baill..Main product in Hubei, ground such as Sichuan, Yunnan, Guizhou.With Radix Et Rhizoma Rhei is good.
Cortex Phellodendri is the dry bark of rutaceae wampee Phellodendron chinense Schneid. (Cortex Phellodendri) or Cortex Phellodendri Phellodendron amurense Rupr. (Cortex Phellodendri).The Cortex Phellodendri main product in Sichuan, ground such as Yunnan, Guizhou, Hubei; The Cortex Phellodendri main product in Jilin, ground such as Liaoning, Heilungkiang, the Inner Mongol.With Cortex Phellodendri is good.
Herba Verbenae is the dry aerial parts of Verenaceae plant Herba Verbenae Verbena officinalis L..Main product in Hubei, ground such as Jiangsu, Guangxi, Guizhou.
Herba Violae is the dry herb of Violaceae Chinese violet Viola yedoensis Makino..Main product in Jiangsu, ground such as Anhui, Zhejiang, Shaanxi, Shanghai.
Radix Salviae Miltiorrhizae is the dry root and rhizome of labiate Radix Salviae Miltiorrhizae Salvia miltiorrhiza Bge..Main product in Sichuan, Shandong, zhejiang and other places.
Radix Bupleuri is the dry root of umbelliferae bupleurum Bupleurum chinense DC. or Radix Bupeuri Scorzonerfolii. Bupleurumscorzonerifolium Willd..Main product in Jilin, ground such as Liaoning, Hebei, Henan, Shandong.With Radix Bupleuri is good.
Semen Vaccariae is the drying and ripening kind of pinkwort Vaccaria segetalis Vaccaria segetalis (Neck.) Garcke.Main product in Hebei, ground such as Heilungkiang, Liaoning, Shandong, Shanxi, Hubei.With Semen Vaccariae (parched) is good.
Pheretima is the dry body of huge earthworm animal Pheretima aspergillum Pheretima aspergillum of section (E.Perrier), popular Pheretimatschiliensis Pheretima vulgaris Chen, William Pheretimatschiliensis Pheretima guillelmi (Michaelsen) or the blind Pheretimatschiliensis Pheretima of comb pectinifera Michaelsen.Main product in Guangdong, ground such as Guangxi, Fujian, Shanghai, Henan, Shandong, Anhui.With LUMBRICUS is good.
Radix Sophorae Flavescentis is the dry root of leguminous plant Radix Sophorae Flavescentis Sophora flavescens Ait..Main product in Shanxi, ground such as Henan, Hebei.
The Radix Astragali is the dry root of leguminous plant Radix Astagali Astragalus membranaceus (Fisch.) Bge.var.mongholicus (Bge.) Hsiao or Radix Astragali Astragalus membranaceus (Fisch.) Bge..Main product in the Inner Mongol, ground such as Shanxi, Jilin, Hebei, Shanxi.
Semen Plantaginis is the dry mature seed of preceding Plantago asiatica L. of Plantaginaceae plant or Plantago depressa Willd Plantago depressa Willd..Main product in Jiangxi, ground such as Henan, Heilungkiang, Liaoning, Hebei.With Semen Plantaginis (parched with salt) is good.
Poria is the dry sclerotia of Polyporaceae fungus Poria Poria cocos (Schw.) Wolf.Main product in Yunnan, ground such as Anhui, Hubei, Henan, Sichuan.
Radix Et Rhizoma Rhei, Herba Verbenae are monarch in the side.The Radix Et Rhizoma Rhei bitter cold, energy eliminating blood stasis and inducing menstruation, removing pathogenic heat from blood and toxic substance from the body, clearing away heat-damp and promoting diuresis; At prostatitis can sterilize, antiinflammatory, can also restrain, pain relieving, for treating prostatitic key medicine.The Herba Verbenae bitter in the mouth is cool in nature, energy promoting blood circulation to remove blood stasis, heat-clearing and toxic substances removing, diuretic dehumidifying.
Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, removing heat from blood are imitated carbuncle.Cortex Phellodendri, Herba Violae removing summer-heat damp-heat in lower-JIAO.Pheretima is longer than collateral dredging, again can diuretic, and clear part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels accumulation of heat makes heat go out from water channel.Radix Salviae Miltiorrhizae, Cortex Phellodendri, Herba Violae, Pheretima are ministerial drug, the clear damp-heat in lower-JIAO of energy, and the while principal drug assistance is invigorated blood circulation, the merit of diuretic.
Poria, Semen Plantaginis relieving stranguria by diuresis draw heresy and go out from urine.Radix Astragali QI invigorating invigorating middle warmer yang invigorating, dirty to end the spleen essence.The Radix Sophorae Flavescentis bitter in the mouth is cold, the function heat clearing and damp drying, and with Qinghua damp-heat in lower-JIAO, tonneau urine is good at, can also wind dispelling insecticide.The sharp blood vessels of Semen Vaccariae, promoting blood circulation to restore menstrual flow are apt to control all pouring.Poria, Semen Plantaginis, the Radix Astragali, Radix Sophorae Flavescentis, Semen Vaccariae are adjuvant drug.
Radix Bupleuri is messenger drug, both can dispersing the stagnated live-QI to relieve the stagnation of QI, can separate the pivot of few sun again; The sick institute of the through cloudy Liver Channel of fainting of priming thing.
This side's compatibility is reasonable, and flavour of a drug are proper, and all medicines are played heat-clearing and toxic substances removing altogether, the treating stranguria merit of invigorating blood circulation.
Beneficial effect of the present invention is:
1, selecting Chinese crude drug for use is raw material, and each component meets the pharmaceutical control and administration rules, utilizes the comprehensive function of the Chinese medicine of respectively distinguishing the flavor of to treat chronic prostatitis, gives full play to the little advantage of herbal toxic effect, nontoxic.
2, the present invention need not to decoct no bitterness sense, taking convenience.
3, heat-clearing and toxic substances removing of the present invention, it is treating stranguria to invigorate blood circulation, and treatment chronic prostatitis effect is remarkable.
Clinical observation shows that obvious effective rate can reach 61.60%, total effective rate 89.60% with these contrivance treatment chronic prostatitis 125 examples.Do blood, urine, just routine and hepatic and renal function inspection before and after the treatment, no abnormality seen changes, and does not find in the medication process that this medicine has tangible untoward reaction.Test shows this contrivance treatment chronic prostatitis determined curative effect, has no side effect.
The specific embodiment
Embodiment 1
Radix Et Rhizoma Rhei 100g Cortex Phellodendri 100g Herba Verbenae 100g Herba Violae 250g Radix Salviae Miltiorrhizae 100g Radix Bupleuri 50g
Semen Vaccariae 100g Pheretima 90g Radix Sophorae Flavescentis 90g Radix Astragali 100g Semen Plantaginis 90g Poria 100g
Radix Et Rhizoma Rhei 70% ethanol extraction; Pheretima, Poria, astragalus membranaceus powder are become coarse powder; 8 flavors such as all the other Cortex Phellodendris boil twice with 10 times decocting, and 3 hours for the first time, 2 hours for the second time; Collecting decoction filters, and filtrate concentrates, and adds powder and Radix Et Rhizoma Rhei ethanol extract such as Pheretima, and is dry below 80 ℃, is ground into fine powder, encapsulated getting final product.Every capsules 0.5g.
Embodiment 2
Radix Et Rhizoma Rhei 300g Cortex Phellodendri 150g Herba Verbenae 200g Herba Violae 400g Radix Salviae Miltiorrhizae 200g Radix Bupleuri 100g
Semen Vaccariae 200g Pheretima 150g Radix Sophorae Flavescentis 150g Radix Astragali 200g Semen Plantaginis 150g Poria 200g
Radix Et Rhizoma Rhei 70% ethanol extraction; Pheretima, Poria, astragalus membranaceus powder are become coarse powder; 8 flavors such as all the other Cortex Phellodendris boil twice with 10 times decocting, and 3 hours for the first time, 2 hours for the second time; Collecting decoction filters, and filtrate concentrates, and adds powder and Radix Et Rhizoma Rhei ethanol extract such as Pheretima, and is dry below 80 ℃, is ground into fine powder, encapsulated getting final product.Every capsules 0.5g.
Embodiment 3
Radix Et Rhizoma Rhei 200g Cortex Phellodendri 120g Herba Verbenae 150g Herba Violae 300g Radix Salviae Miltiorrhizae 150g Radix Bupleuri 60g
Semen Vaccariae 150g Pheretima 100g Radix Sophorae Flavescentis 100g Radix Astragali 150g Semen Plantaginis 100g Poria 150g
Radix Et Rhizoma Rhei 70% ethanol extraction; Pheretima, Poria, astragalus membranaceus powder are become coarse powder; 8 flavors such as all the other Cortex Phellodendris boil twice with 10 times decocting, and 3 hours for the first time, 2 hours for the second time; Collecting decoction filters, and filtrate concentrates, and adds powder and Radix Et Rhizoma Rhei ethanol extract such as Pheretima, and is dry below 80 ℃, is ground into fine powder, encapsulated getting final product.Every capsules 0.5g.
Claims (4)
1. a pharmaceutical composition for the treatment of chronic prostatitis is characterized in that raw material contains following medicaments in part by weight: 5～40 parts of Radix Et Rhizoma Rhei, 9～20 parts of Cortex Phellodendris, 10～30 parts of Herba Verbenae, 20～50 parts of Herba Violaes, 10～30 parts of Radix Salviae Miltiorrhizaes, 3～15 parts of Radix Bupleuri, 10～30 parts of Semen Vaccariae, 5～20 parts of Pheretimas, 5～20 parts of Radix Sophorae Flavescentiss, 10～30 parts of the Radixs Astragali, 5～20 parts of Semen Plantaginiss, 10～30 parts in Poria.
2. require the pharmaceutical composition of described treatment chronic prostatitis according to right 1, it is characterized in that raw material contains following medicaments in part by weight: 10～30 parts of Radix Et Rhizoma Rhei, 10～15 parts of Cortex Phellodendris, 10～20 parts of Herba Verbenae, 25～40 parts of Herba Violaes, 10～20 parts of Radix Salviae Miltiorrhizaes, 5～10 parts of Radix Bupleuri, 10～20 parts of Semen Vaccariae, 9～15 parts of Pheretimas, 9～15 parts of Radix Sophorae Flavescentiss, 10～20 parts of the Radixs Astragali, 9～15 parts of Semen Plantaginiss, 10～20 parts in Poria.
3. require the pharmaceutical composition of described treatment chronic prostatitis according to right 1,2, it is characterized in that the optimised quantity of each raw material is: 20 parts of Radix Et Rhizoma Rhei, 12 parts of Cortex Phellodendris, 15 parts of Herba Verbenae, 30 parts of Herba Violaes, 15 parts of Radix Salviae Miltiorrhizaes, 6 parts of Radix Bupleuri, 15 parts of Semen Vaccariae, 10 parts of Pheretimas, 10 parts of Radix Sophorae Flavescentiss, 15 parts of the Radixs Astragali, 10 parts of Semen Plantaginiss, 15 parts in Poria.
4. require described medicine according to right 3, Radix Et Rhizoma Rhei is standby with 70% ethanol extraction; Pheretima, Poria, astragalus membranaceus powder become coarse powder; 8 flavors such as all the other Cortex Phellodendris boil twice with 8～10 times decocting, and collecting decoction filters, and filtrate concentrates, and adds powder and Radix Et Rhizoma Rhei ethanol extract such as Pheretima, and are dry below 80 ℃, are ground into fine powder, encapsulated.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101783333A CN101199687A (en) | 2007-11-29 | 2007-11-29 | Medicament compound for treating chronic prostatitis and preparing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101783333A CN101199687A (en) | 2007-11-29 | 2007-11-29 | Medicament compound for treating chronic prostatitis and preparing method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101199687A true CN101199687A (en) | 2008-06-18 |
Family
ID=39515169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101783333A Pending CN101199687A (en) | 2007-11-29 | 2007-11-29 | Medicament compound for treating chronic prostatitis and preparing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101199687A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103432270A (en) * | 2013-07-31 | 2013-12-11 | 唐国萍 | Traditional Chinese medicine composition for treating chronic prostatitis |
| CN106236943A (en) * | 2016-08-22 | 2016-12-21 | 吴斌 | A kind of medicine for treating chronic prostatitis |
| CN108888729A (en) * | 2018-10-11 | 2018-11-27 | 吉林省德商药业股份有限公司 | A kind of preparation method of prostatitis Chinese medicine composition |
-
2007
- 2007-11-29 CN CNA2007101783333A patent/CN101199687A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103432270A (en) * | 2013-07-31 | 2013-12-11 | 唐国萍 | Traditional Chinese medicine composition for treating chronic prostatitis |
| CN106236943A (en) * | 2016-08-22 | 2016-12-21 | 吴斌 | A kind of medicine for treating chronic prostatitis |
| CN108888729A (en) * | 2018-10-11 | 2018-11-27 | 吉林省德商药业股份有限公司 | A kind of preparation method of prostatitis Chinese medicine composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100531771C (en) | Medicine for treating chronic pelvic inflammation and its preparation method | |
| CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN101199687A (en) | Medicament compound for treating chronic prostatitis and preparing method thereof | |
| CN113209194B (en) | Composition for treating chronic gastritis and preparation method and application thereof | |
| CN106334171A (en) | Traditional Chinese medicine preparation for repairing liver damage and preparation method thereof | |
| CN102755519B (en) | Kudzuvine root-kudzuvine flower anti-canker sore particle and preparation method thereof | |
| CN105535855A (en) | Traditional Chinese medicinal composition for treating hepatitis B and preparation method thereof | |
| CN105343847A (en) | Traditional Chinese medicine composition for treating eczema containing folium artemisiae argyi and preparing method thereof | |
| CN105327244A (en) | Traditional Chinese medicine composition containing folium artemisiae argyi and used for treating bedsores and preparing method thereof | |
| CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
| CN111214584B (en) | Traditional Chinese medicine composition for tonifying kidney and benefiting liver as well as preparation method and application thereof | |
| CN102335243B (en) | Chinese medicinal composition for treating icteric hepatitis | |
| CN109646545B (en) | Externally applied anti-infection traditional Chinese medicine and preparation method and application thereof | |
| CN102145119B (en) | Traditional Chinese medicinal composition for treating pulmonary heart diseases | |
| CN105362849A (en) | Method for preparing traditional Chinese medicine composition for treating infertility | |
| CN105343309A (en) | Pharmaceutical composition for treating haemorrhoids containing moringa oleifera leaves and preparing method thereof | |
| CN104983982A (en) | Traditional Chinese medicine composition for treating hemorrhoid and preparation method thereof | |
| CN102698224A (en) | Traditional Chinese medicament for treating pulmonary interstitial fibrosis | |
| CN115025171A (en) | Traditional Chinese medicine composition and preparation for treating autoimmune diseases and preparation method thereof | |
| CN112089781A (en) | External medicine formula for treating thyroid cancer in traditional Chinese medicine manner and preparation method of external medicine formula | |
| CN114306442A (en) | Traditional Chinese medicine composition for treating atopic dermatitis and application thereof | |
| CN113521191A (en) | Traditional Chinese medicine composition for treating non-severe aplastic anemia and preparation method thereof | |
| CN115252729A (en) | Traditional Chinese medicine composition for treating diabetes and application thereof | |
| CN103655935A (en) | Traditional Chinese medicine composition for treating hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20080618 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |